Newton, MA, United States of America

Yuriy Gankin

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019-2021

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yuriy Gankin: Innovator in Cancer Treatment

Introduction

Yuriy Gankin, an accomplished inventor located in Newton, MA, USA, has made significant contributions to the field of cancer treatment. With three patents to his name, Gankin is at the forefront of innovative therapies targeting neoplastic conditions. His work, particularly in the treatment of quiescent cancer cells, showcases his commitment to advancing medical science.

Latest Patents

Gankin's latest patents focus on "Combinations for the treatment of neoplasms using quiescent cell targeting with EGFR inhibitors." This invention encompasses compositions and methods aimed at effectively treating neoplasms, particularly through the targeting of dormant cancer cells with therapeutic agents. The approach combines these agents with other treatments effective against various neoplastic conditions, specifically those involving anti-cancer agents that inhibit the epidermal growth factor receptor (EGFR). The significance of Gankin's work lies in its potential to enhance treatment efficacy for patients battling cancer.

Career Highlights

Currently, Yuriy Gankin is associated with Felicitex Therapeutics, Inc., where he continues to innovate and develop treatments aimed at improving patient outcomes in oncology. His expertise in the realm of therapeutic compositions places him among the leading figures in cancer research and treatment advancement.

Collaborations

Gankin collaborates with fellow researchers and professionals, notably Maria Vilenchik and Michael Frid. Such partnerships contribute to a dynamic environment where innovative ideas can flourish and enhance the potential for groundbreaking advancements in cancer therapies.

Conclusion

As an inventor, Yuriy Gankin exemplifies the spirit of innovation within the healthcare sector. His work in targeting quiescent cancer cells with EGFR inhibitors has the potential to revolutionize treatment methodologies for neoplasms. With continued research and collaboration, Gankin's inventions stand to make a noteworthy impact on cancer treatment, providing hope for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…